What is the CVR number of LIPLASOME PHARMA ApS?

LIPLASOME PHARMA ApS is registered with CVR / Virk under CVR 29428514.

What is the revenue of LIPLASOME PHARMA ApS?

LIPLASOME PHARMA ApS reported revenue of DKK -28K in 2025.

LIPLASOME PHARMA ApS employs 2 people as of the latest annual report.

Hans-Henrik Horsted Eriksen is the CEO of LIPLASOME PHARMA ApS, in role since 2012.

John Riis Mortensen chairs the board of LIPLASOME PHARMA ApS, in role since 2012.

LIPLASOME PHARMA ApS's registered address is Tabletvej 1.

APSActiveAdvertising protection

Actively employed in the business

Name	Role	Member since
Current (1)
HH Hans-Henrik Horsted Eriksen Chief Executive Officer	Chief Executive Officer	2012

Non-executive oversight

Name	Role	Member since
Current (2)
SK Sanjay Kumar Sehgal Board of Directors	Board of Directors	2016
JR John Riis Mortensen Chairman	Chairman	2012
Former (8)
CB Claus Bagger-Sørensen Board of Directors	Board of Directors	2006 – 2012
TV Torben Vilsgaard Board of Directors	Board of Directors	2011 – 2012
OL Ole Lund Board of Directors	Board of Directors	2006 – 2011
DM Duncan Moore Board of Directors	Board of Directors	2012 – 2016
HB Holger Bagger-Sørensen Chairman	Chairman	2006 – 2012
TB Torben Brøgger-Mikkelsen Board of Directors	Board of Directors	2006 – 2012
SB Steen Bagger-Sørensen Board of Directors	Board of Directors	2006 – 2012
PB Peter Buhl Board of Directors	Board of Directors	2008 – 2016

As of last annual report

Shareholder	Type	Ownership	Votes	Since
BAGGER-SØRENSEN & CO. A/S	Company	90–99.99%	90–99.99%	2022
VECATA INVEST ApS	Company	90–99.99%	90–99.99%	2012

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.